Best Practice & Research Clinical Haematology
Volume 21, Issue 1 , Pages 21-28 , March 2008

Has gene expression profiling improved diagnosis, classification, and outcome prediction in AML?

  • Cheryl L. Willman, MD (The Maurice and Marguerite Liberman Distinguished Chair in Cancer Research Director & CEO)

      Affiliations

    • Corresponding Author InformationTel.: +1 505 272 5622; Fax: +1 505 272 4039.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(07)00098-9

doi: 10.1016/j.beha.2007.11.008

Best Practice & Research Clinical Haematology
Volume 21, Issue 1 , Pages 21-28 , March 2008

Article Tools

* Image Usage & Resolution